Danaher (NYSE:DHR – Free Report) had its price target decreased by Robert W. Baird from $277.00 to $268.00 in a research note released on Tuesday. Robert W. Baird currently has an overweight rating on the conglomerate’s stock.
Several other analysts have also commented on the company. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective on the stock in a report on Thursday, October 31st. Stephens reissued an “overweight” rating and issued a $315.00 price target on shares of Danaher in a research note on Wednesday, October 23rd. UBS Group reduced their price objective on shares of Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research report on Wednesday, October 23rd. TD Cowen boosted their target price on shares of Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Finally, Citigroup decreased their price target on shares of Danaher from $305.00 to $285.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Six research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat, Danaher currently has an average rating of “Moderate Buy” and a consensus target price of $285.81.
Check Out Our Latest Stock Report on Danaher
Danaher Trading Down 1.1 %
Danaher Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be issued a $0.27 dividend. The ex-dividend date is Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.44%. Danaher’s payout ratio is 20.61%.
Institutional Trading of Danaher
Institutional investors have recently made changes to their positions in the company. Heck Capital Advisors LLC acquired a new stake in Danaher during the fourth quarter worth $27,000. Decker Retirement Planning Inc. purchased a new position in shares of Danaher during the 4th quarter worth $31,000. Golden State Wealth Management LLC acquired a new stake in shares of Danaher during the 4th quarter worth about $31,000. Strategic Financial Concepts LLC purchased a new stake in Danaher in the 4th quarter valued at about $31,000. Finally, Teachers Insurance & Annuity Association of America acquired a new position in Danaher in the third quarter valued at about $39,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
- Five stocks we like better than Danaher
- Differences Between Momentum Investing and Long Term Investing
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- The Role Economic Reports Play in a Successful Investment Strategy
- What Does the Future Hold for Eli Lilly?
- Investing In Preferred Stock vs. Common Stock
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.